Prescribing Psychotropics bridges the gap between the complexities of drug pharmacokinetics and everyday clinical practice, providing clinicians more insight into how psychiatric drugs behave (or misbehave!) once their patients take them.
I wish I could recall who recently recommended the latest Norton Neuroscience book. It is superb. Dan Hill’s Affect Regulation Theory: A Clinical Model (Norton Series on Interpersonal Neurobiology) speaks to this important natural tension. Allan Schore did the forward. Don’t be fooled: while Schore and Hill hint the that the first part of the book is a review of Schore’s brilliant affect regulation books of the past, it is far more up to date and offers an elegant model of the central and natural tension between shame and pride that impacts the formation of attachment patterns early on through adulthood and does so in the context of dyadic work that me and my colleagues are accustomed to. I underlined a lot of pearls.
The discussions are an enlightening explication of attachment styles and personality, including different kinds of narcissism and borderline styles, and as such is very helpful in supporting good approaches to managing and helping people we work with every day. I was waiting to see if he deals with the individual differences that we see in SPD and ASD. He hinted he would. Even though he doesn’t this book provides a model for predicting the impact of such difficulties on the character style of the developing child. Very useful.
You Might Also Enjoy...
Prescribing Psychotropics bridges the gap between the complexities of drug pharmacokinetics and everyday clinical practice, providing clinicians more insight into how psychiatric drugs behave (or misbehave!) once their patients take them.
As leaders we want to be kind while being effective, and this can be difficult. How do make sure that we do not become tired and angry but instead stay fresh and creative? Hear Zoe Kernohan Neely, Josh Feder MD & Jerri Lynn Hogg PhD in three mini videos.
This deep dive podcast breaks through the dogma of autism intervention and helps you to understand three main branches of autism intervention and their very different mechanisms, with a huge shift in our understanding of what works.
Positive Development is a start-up aiming to change the culture of the current state of autism treatment so that it opens the door for evidence-based developmental approaches for autism that are much more humane.
We break down three main autism intervention approaches, and provide you with information that will help you improve on your abilities to recognize which particular autism intervention might be best for a specific patient.
It's all over the internet: a new non-stimulant medication approved by the FDA for treatment of ADHD. but is Viloxazine (Qelbree) going to be a game changer? Find out!